Intermediate-Term Oncologic Outcome Assessment for Robot-Assisted Radical Prostatectomy: Comparing Retzius-Sparing with Standard Approach in a Randomized Control Cohort

Ghassan A Barayan; Sami E Majdalany; Mohit Butaney; Deepansh Dalela; James Peabody; Firas Abdolla; Mani Menon; Wooju Jeong

doi:10.1089/end.2023.0514

Back

Intermediate-Term Oncologic Outcome Assessment for Robot-Assisted Radical Prostatectomy: Comparing Retzius-Sparing with Standard Approach in a Randomized Control Cohort

Journal article

Peer reviewed

Intermediate-Term Oncologic Outcome Assessment for Robot-Assisted Radical Prostatectomy: Comparing Retzius-Sparing with Standard Approach in a Randomized Control Cohort

Ghassan A Barayan, Sami E Majdalany, Mohit Butaney, Deepansh Dalela, James Peabody, Firas Abdolla, Mani Menon and Wooju Jeong

Journal of endourology, Vol.38(6), pp.559-563

06/01/2024

DOI: 10.1089/end.2023.0514

PMID: 38429913

View Online

Abstract

Retzius-sparing prostatectomy was promoted with the early continence result. The long-term oncologic outcome is still unknown. In this study, we aimed to compare the intermediate-term oncologic outcomes of these two approaches in patients' cohort who were treated as part of a randomized controlled trial. A total of 120 patients were previously randomized equally to receive Retzius-sparing robot-assisted laparoscopic radical prostatectomy (RS-RARP) standard robot-assisted laparoscopic radical prostatectomy (S-RARP) between January 2015 and April 2016. Baseline, surgical, and pathologic characteristics as well as oncologic outcomes were assessed. The analysis was done based on the treatment received. Sixty-three patients underwent S-RARP, whereas 57 patients underwent RS-RARP. There was no statistically significant difference in the baseline nor surgical characteristics. The median follow-up was 71.24 (interquartile range: 59.75-75.75) months. There were more pathologic T3 diseases in RS-RARP. There was no significant difference in the positive margin status nor in the biochemical recurrence (BCR) rate among both groups. After S-RARP and RS-RARP, 6 and 10 patients had BCR, and the 5 years BCR-free survival was 91% and 85%, respectively ( = 0.21). In this cohort, there was no difference in BCR in the patients who received either technique. Further multi-institutional studies with a larger sample size and longer follow-up are required.

Aged

Cohort Studies

Humans

Laparoscopy - methods

Male

Middle Aged

Organ Sparing Treatments - methods

Prostatectomy - methods

Prostatic Neoplasms - pathology

Prostatic Neoplasms - surgery

Robotic Surgical Procedures - methods

Treatment Outcome

Details

Title: Subtitle: Intermediate-Term Oncologic Outcome Assessment for Robot-Assisted Radical Prostatectomy: Comparing Retzius-Sparing with Standard Approach in a Randomized Control Cohort
Creators: Ghassan A Barayan - Umm al-Qura University
Sami E Majdalany - Henry Ford Hospital
Mohit Butaney - Henry Ford Hospital
Deepansh Dalela - Henry Ford Health System
James Peabody - Henry Ford Hospital
Firas Abdolla - Henry Ford Hospital
Mani Menon - Mount Sinai Health System
Wooju Jeong - Henry Ford Hospital
Resource Type: Journal article
Publication Details: Journal of endourology, Vol.38(6), pp.559-563
DOI: 10.1089/end.2023.0514
PMID: 38429913
NLM abbreviation: J Endourol
ISSN: 0892-7790
eISSN: 1557-900X
Language: English
Date published: 06/01/2024
Academic Unit: Urology
Record Identifier: 9984949187502771

Metrics

4 Record Views

See more details